サマリー

婦人科系癌治療薬の世界市場 2022-2026 年
Technavioは婦人科癌治療薬市場を監視しており、2022-2026年の間に142億2000万ドルの成長が見込まれ、予測期間中に14.67%のCAGRで加速しています。当レポートでは、婦人科癌治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。婦人科系癌の発生率の増加、強力なパイプラインと新薬の承認、患者支援プログラムの増加などが市場を牽引しています。
婦人科系癌治療薬市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioの婦人科系がん治療薬市場は、以下のように区分されています。
タイプ別
- 子宮癌
- 卵巣癌
- 子宮頸がん
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、新規治療法の出現が、今後数年間の婦人科がん治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、高度な診断方法の利用可能性と婦人科系癌に対する意識の高まりが、市場の大きな需要につながると考えられます。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な図を提示します。婦人科系癌の治療薬市場に関する当レポートは、以下の分野をカバーしています。
- 婦人科系癌の治療薬市場のサイジング
- 婦人科系癌の治療薬市場の予測
- 婦人科系癌治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie社、Amgen社、AstraZeneca Plc、Becton Dickinson and Co、Biocon Ltd、Bristol Myers Squibb Co、Clovis Oncology Inc、第一三共Inc.ホフマン・ラ・ロシュ社、グラクソ・スミスクライン社、イミュノジェン社、ジョンソン・アンド・ジョンソン社、カリオファーム・セラピューティクス社、メルク・アンド・カンパニー社、ノバルティス社、アボット社などInc.、Novartis AG、Pfizer Inc.、Sanofi、Siemens Healthcare GmbH、Teva Pharmaceutical Industries Ltd.の7社が含まれています。また、婦人科癌治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/gynecological-cancers-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Uterine cancer - Market size and forecast 2021-2026
o Exhibit 28: Chart on Uterine cancer - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Uterine cancer - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Uterine cancer - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Uterine cancer - Year-over-year growth 2021-2026 (%)
o 5.4 Ovarian cancer - Market size and forecast 2021-2026
o Exhibit 32: Chart on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Ovarian cancer - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Ovarian cancer - Year-over-year growth 2021-2026 (%)
o 5.5 Cervical cancer - Market size and forecast 2021-2026
o Exhibit 36: Chart on Cervical cancer - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Cervical cancer - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Cervical cancer - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Cervical cancer - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Type
o Exhibit 44: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.9 Germany - Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 UK - Market size and forecast 2021-2026
o Exhibit 82: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 93: AbbVie Inc. - Overview
o Exhibit 94: AbbVie Inc. - Product / Service
o Exhibit 95: AbbVie Inc. - Key offerings
o 10.4 Amgen Inc.
o Exhibit 96: Amgen Inc. - Overview
o Exhibit 97: Amgen Inc. - Product / Service
o Exhibit 98: Amgen Inc. - Key offerings
o 10.5 AstraZeneca Plc
o Exhibit 99: AstraZeneca Plc - Overview
o Exhibit 100: AstraZeneca Plc - Product / Service
o Exhibit 101: AstraZeneca Plc - Key news
o Exhibit 102: AstraZeneca Plc - Key offerings
o 10.6 Bristol Myers Squibb Co.
o Exhibit 103: Bristol Myers Squibb Co. - Overview
o Exhibit 104: Bristol Myers Squibb Co. - Product / Service
o Exhibit 105: Bristol Myers Squibb Co. - Key offerings
o 10.7 Clovis Oncology Inc.
o Exhibit 106: Clovis Oncology Inc. - Overview
o Exhibit 107: Clovis Oncology Inc. - Business segments
o Exhibit 108: Clovis Oncology Inc. - Key offerings
o Exhibit 109: Clovis Oncology Inc. - Segment focus
o 10.8 Daiichi Sankyo Co. Ltd.
o Exhibit 110: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 111: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 112: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 113: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 114: Daiichi Sankyo Co. Ltd. - Segment focus
o 10.9 Eli Lilly and Co.
o Exhibit 115: Eli Lilly and Co. - Overview
o Exhibit 116: Eli Lilly and Co. - Product / Service
o Exhibit 117: Eli Lilly and Co. - Key offerings
o 10.10 F. Hoffmann La Roche Ltd.
o Exhibit 118: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 119: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 120: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 121: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 122: F. Hoffmann La Roche Ltd. - Segment focus
o 10.11 GlaxoSmithKline Plc
o Exhibit 123: GlaxoSmithKline Plc - Overview
o Exhibit 124: GlaxoSmithKline Plc - Business segments
o Exhibit 125: GlaxoSmithKline Plc - Key news
o Exhibit 126: GlaxoSmithKline Plc - Key offerings
o Exhibit 127: GlaxoSmithKline Plc - Segment focus
o 10.12 Merck and Co. Inc.
o Exhibit 128: Merck and Co. Inc. - Overview
o Exhibit 129: Merck and Co. Inc. - Business segments
o Exhibit 130: Merck and Co. Inc. - Key news
o Exhibit 131: Merck and Co. Inc. - Key offerings
o Exhibit 132: Merck and Co. Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 133: Inclusions checklist
o Exhibit 134: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 135: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 136: Research methodology
o Exhibit 137: Validation techniques employed for market sizing
o Exhibit 138: Information sources
o 11.5 List of abbreviations
o Exhibit 139: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Uterine cancer - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Uterine cancer - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Uterine cancer - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Uterine cancer - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Ovarian cancer - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Ovarian cancer - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Cervical cancer - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Cervical cancer - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Cervical cancer - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Cervical cancer - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Type ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: AbbVie Inc. - Overview
Exhibits94: AbbVie Inc. - Product / Service
Exhibits95: AbbVie Inc. - Key offerings
Exhibits96: Amgen Inc. - Overview
Exhibits97: Amgen Inc. - Product / Service
Exhibits98: Amgen Inc. - Key offerings
Exhibits99: AstraZeneca Plc - Overview
Exhibits100: AstraZeneca Plc - Product / Service
Exhibits101: AstraZeneca Plc - Key news
Exhibits102: AstraZeneca Plc - Key offerings
Exhibits103: Bristol Myers Squibb Co. - Overview
Exhibits104: Bristol Myers Squibb Co. - Product / Service
Exhibits105: Bristol Myers Squibb Co. - Key offerings
Exhibits106: Clovis Oncology Inc. - Overview
Exhibits107: Clovis Oncology Inc. - Business segments
Exhibits108: Clovis Oncology Inc. - Key offerings
Exhibits109: Clovis Oncology Inc. - Segment focus
Exhibits110: Daiichi Sankyo Co. Ltd. - Overview
Exhibits111: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits112: Daiichi Sankyo Co. Ltd. - Key news
Exhibits113: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits114: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits115: Eli Lilly and Co. - Overview
Exhibits116: Eli Lilly and Co. - Product / Service
Exhibits117: Eli Lilly and Co. - Key offerings
Exhibits118: F. Hoffmann La Roche Ltd. - Overview
Exhibits119: F. Hoffmann La Roche Ltd. - Business segments
Exhibits120: F. Hoffmann La Roche Ltd. - Key news
Exhibits121: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits122: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits123: GlaxoSmithKline Plc - Overview
Exhibits124: GlaxoSmithKline Plc - Business segments
Exhibits125: GlaxoSmithKline Plc - Key news
Exhibits126: GlaxoSmithKline Plc - Key offerings
Exhibits127: GlaxoSmithKline Plc - Segment focus
Exhibits128: Merck and Co. Inc. - Overview
Exhibits129: Merck and Co. Inc. - Business segments
Exhibits130: Merck and Co. Inc. - Key news
Exhibits131: Merck and Co. Inc. - Key offerings
Exhibits132: Merck and Co. Inc. - Segment focus
Exhibits133: Inclusions checklist
Exhibits134: Exclusions checklist
Exhibits135: Currency conversion rates for US$
Exhibits136: Research methodology
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Information sources
Exhibits139: List of abbreviations